Is McCune-Albright syndrome overlooked in subjects with fibrous dysplasia of bone?

Journal of Pediatrics

Volumn 142, Issue 5, 2003, Pages 532-538

  Hannon, Tamara S ^a   Noonan, Ken ^b   Steinmetz, Rosemary ^b   Eugster, Erica A ^b   Levine, Michael A ^b   Pescovitz, Ora Hirsch ^b  

^a RILEY HOSPITAL FOR CHILDREN   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA;

ADOLESCENT; ALBRIGHT SYNDROME; ARTICLE; CAFE AU LAIT SPOT; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; ENDOCRINE DISEASE; FEMALE; FIBROUS DYSPLASIA; GENE MUTATION; HIGH RISK POPULATION; HUMAN; HYPERTHYROIDISM; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; THYROIDECTOMY;

EID: 0038696450     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2003.153     Document Type: Article

References (25)

1. Mauras N, Blizzard RM. The McCune-Albright syndrome. Acta Endocrinol Suppl (Copenh) 1986;279:207-17.
2. Feuillan PP. McCune-Albright syndrome. Curr Ther Endocrinol Metab 1994;5:205-9.
3. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 1991;325:1688-95.
4. Schwindinger WF, Francomano CA, Levine MA. Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci U S A 1992;89:5152-6.
5. Shenker A, Weinstein LS, Sweet DE, Spiegel AM. An activating Gs alpha mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome. J Clin Endocrinol Metab 1994;79:750-5.
6. Collins MT, Shenker A. McCune-Albright syndrome: new insights. Curr Opin Endocrinol Diabetes 1999;6:119-25.
7. Speigel AM, Weinstein LS, Shenker A. Abnormalities in G protein-coupled signal transduction pathways in human disease. J Clin Invest 1993;92:1119-25.
8. Marie PJ. Cellular and molecular basis of fibrous dysplasia. Histol Histopathol 2001;16:981-8.
9. Kim IS, Kim ER, Nam HJ, Chin MO, Moon YH, Oh MR, et al. Activating mutation of GS alpha in McCune-Albright syndrome causes skin pigmentation by tyrosinase gene activation on affected melanocytes. Horm Res 1999;52:235-40.
10. Candeliere GA, Roughley PJ, Glorieux FH. Polymerase chain reaction-based technique for the selective enrichment and analysis of mosaic arg201 mutations in G alpha s from patients with fibrous dysplasia of bone. Bone 1997;2:201-6.
11. Riminucci M, Liu B, Corsi A, Shenker A, Spiegel AM, Robey PG, et al. The histopathology of fibrous dysplasia of bone in patients with activating mutations of the Gs alpha gene: site-specific patterns and recurrent histological hallmarks. J Pathol 1999;187:249-58.
12. Suarez HG, du Villard JA, Caillou B, Schlumberger M, Parmentier C, Monier R. gsp mutation in human thyroid tumours. Oncogene 1991;6:677-9.
13. Shi Y, Tang D, Deng J, Su C. Detection of gsp oncogene in growth hormone-secreting pituitary adenomas and the study of clinical characteristics of acromegalic patients with gsp-positive pituitary tumors. Chin Med J (Engl) 1998;111:891-4.
14. Lyons J, Landis CA, Harsh G, Vallar L, Grunewald K, Feichtinger H, et al. Two G protein oncogenes in human endocrine tumors. Science 1990;249:655-9.
15. Shenker A, Weinstein LS, Moran A, Pescovitz OH, Charest NJ, Boney CM, et al. Severe endocrine and nonendocrine manifestations of the McCune-Albright syndrome associated with activating mutations of stimulatory G protein GS. J Pediatr 1993;123:509-18.
16. Feuillan PP. McCune-Albright syndrome. Curr Ther Endocrinol Metab 1997;6:235-9.
17. de Sanctis C, Lala R, Matarazzo P, Balsamo A, Bergamaschi R, Cappa M, et al. McCune-Albright syndrome: a longitudinal clinical study of 32 patients. J Pediatr Endocrinol Metab 1999;12:817-26.
18. Di Candia S, Weber G, Mora S, de Pellegrin M, Chiumello G. Early fractures and occult hyperthyroidism: McCune-Albright syndrome? Horm Res 2001;56:58-62.
19. Firat D, Stutzman L. Fibrous dysplasia of the bone: review of twenty-four cases. Am J Med 1968;44:421-9.
20. Isotani H, Sanda K, Kameoka K, Takamatsu J. McCune-Albright syndrome associated with non-autoimmune type of hyperthyroidism with development of thyrotoxic crisis. Horm Res 2000;53:256-9.
21. Bianco P, Riminucci M, Majolagbe A, Kuznetsov SA, Collins MT, Mankani MH, et al. Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone. J Bone Miner Res 2000;15:120-8.
22. Ding C, Deng Z, Levine MA. A highly sensitive PCR method detects activating mutations of the GNAS1 gene in peripheral blood cells of patients with McCune-Albright syndrome or isolated fibrous dysplasia [abstract]. Am Soc Bone Miner Res 2001;SU454.
23. Cowen PJ, Sargent PA. Changes in plasma prolactin during SSRI treatment: evidence for a delayed increase in 5-HT neurotransmission. J Psychopharmacol 1997;11:345-8.
24. Kavoussi RJ, Kramer J, Hauger RI, Coccaro EF. Prolactin response to D-fenfluramine in outpatients with major depression. Psychiatry Res 1998;79:199-205.
25. Coutant R, Lumbroso S, Rey R, Lahlou N, Venara M, Rouleau S, et al. Macroorchidism due to autonomous hperfunction of Sertoli cells and G(s)alpha gene mutation: an unusual expression of McCune-Albright syndrome in a prepubertal boy. J Clin Endocrinol Metab 2001;86:1778-81.